OTCMKTS:YECO

EV Biologics Stock Forecast, Price & News

$3.50
0.00 (0.00 %)
(As of 08/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.50
$3.50
50-Day Range
$3.00
$4.98
52-Week Range
$0.10
$6.37
Volume404 shs
Average Volume3,093 shs
Market Capitalization$22.49 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.27
30 days | 90 days | 365 days | Advanced Chart
Receive YECO News and Ratings via Email

Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter.


About EV Biologics

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











EV Biologics (OTCMKTS:YECO) Frequently Asked Questions

What stocks does MarketBeat like better than EV Biologics?

Wall Street analysts have given EV Biologics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but EV Biologics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has EV Biologics' stock been impacted by Coronavirus (COVID-19)?

EV Biologics' stock was trading at $5.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, YECO stock has decreased by 31.1% and is now trading at $3.50.
View which stocks have been most impacted by COVID-19
.

Who are EV Biologics' key executives?

EV Biologics' management team includes the following people:
  • Mr. Daniel S. McKinney, Founder, Chairman & CEO (Age 59)

Who are some of EV Biologics' key competitors?

What is EV Biologics' stock symbol?

EV Biologics trades on the OTCMKTS under the ticker symbol "YECO."

How do I buy shares of EV Biologics?

Shares of YECO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is EV Biologics' stock price today?

One share of YECO stock can currently be purchased for approximately $3.50.

How much money does EV Biologics make?

EV Biologics has a market capitalization of $22.49 million.

How many employees does EV Biologics have?

EV Biologics employs 284 workers across the globe.

What is EV Biologics' official website?

The official website for EV Biologics is www.evbiologics.com.

Where are EV Biologics' headquarters?

EV Biologics is headquartered at EASTERN END OF XIWUZHUANG VILLAGE JIAODIAN TOWN XINHUA AREA, PINGDINGSHAN F4, 00000.

How can I contact EV Biologics?

EV Biologics' mailing address is EASTERN END OF XIWUZHUANG VILLAGE JIAODIAN TOWN XINHUA AREA, PINGDINGSHAN F4, 00000. The company can be reached via phone at 646 952 8836 or via email at [email protected]


This page was last updated on 8/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.